...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: otc zen

You could say the same about BTI.  People don't bid up stocks unless they see a good probability of major events or a payoff coming in the near future. 

Share
New Message
Please login to post a reply